Stereotaxis Surpasses 75,000 Procedures With Remote Magnetic Navigation System

Stereotaxis, Inc., a leading provider of innovative technologies for the treatment of cardiac arrhythmias, announced that more than 75,000 patient cases have been completed with its remote magnetic navigation technology. The Company also announced that it will present the latest enhancements and clinical data for its industry leading robotic platform at the International AF Symposium, January 8-10, 2015 in Orlando, FL (Booth #816). Now in its 20^th year, the annual three-day symposium brings together the world's leading medical scientists and providers to discuss the most recent advances in the field of atrial fibrillation.

First commercialized in 2003, Stereotaxis remote magnetic navigation technology is designed for the safe, effective and efficient facilitation of complex cardiac ablation. The Company's fourth generation remote navigation system, the Niobe® ES system, was launched in December 2011 and, together with its Vdrive® robotic navigation system and Odyssey™ solutions portfolio, comprises the Epoch™ Solution, a fully remote electrophysiology (EP) platform. Today, the Niobe system is installed in 177 EP sites worldwide and supported by over 200 peer-reviewed publications.

"The expanding experiential and clinical body of evidence continues to confirm the outstanding performance of our Epoch platform in safety, procedure efficiency and outcomes," said William C. Mills, Stereotaxis Chief Executive Officer. "We are excited to advance the dialogue with the International AF Symposium participants concerning the immediate and long-term efficacy of our system in treating complex arrhythmias through ablation therapy."

During a Product Theatre lunch session on January 8, Stereotaxis physician users will discuss how Stereotaxis' latest advancements are improving the success of their ablation programs. Moderated by Dr. Andrea Natale, Executive Director for the Texas Cardiac Arrhythmia Institute at St. David's Medical Center in Austin, TX, the afternoon's presenters include Dr. David Burkhardt (Texas Cardiac Arrhythmia Institute), Dr. William Spear (Advocate Christ Medical Center, Oak Lawn, IL) and Dr. Erik Wissner (Asklepios Klinik St. Georg, Hamburg, Germany).

About Stereotaxis

Stereotaxis is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. Over 100 issued patents support the Stereotaxis platform, which helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Stereotaxis' core Epoch™ Solution includes the Niobe® ES remote magnetic navigation system, the Odyssey® portfolio of lab optimization, networking and patient information management systems and the Vdrive™ robotic navigation system and consumables.

The core components of Stereotaxis systems have received regulatory clearance in the U.S., European Union, Canada, China, Japan and elsewhere. The V-Sono™ ICE catheter manipulator, V-Loop™ variable loop catheter manipulator and V-CAS™ catheter advancement system have received U.S. clearance. For more information, please visit www.stereotaxis.com.